Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China

BACKGROUND: Posaconazole is confirmed to be more effective for preventing invasive fungal infections (IFIs) than first-generation triazoles (fluconazole and itraconazole), but its economic value has not been comprehensively evaluated in China. This study compared the cost-effectiveness of these two...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Changcheng, Ye, Jian, Xie, Yaping, Dong, Rong, Jin, Weizhong, Wang, Linling, Fang, Yingying, Shan, Qiyuan, Lin, Nengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152267/
https://www.ncbi.nlm.nih.gov/pubmed/35655452
http://dx.doi.org/10.3389/fpubh.2022.884846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152267/
https://www.ncbi.nlm.nih.gov/pubmed/35655452
http://dx.doi.org/10.3389/fpubh.2022.884846

Ejemplares similares